Data science is shaping our discovery and development efforts
We are using advanced data science and neuroinformatics to map drug targets to specific brain circuitry and corresponding behaviors.
Stay informed about our latest developments
- January 4, 2019 BlackThorn Therapeutics Announces R&D Updates
- November 2, 2018 BlackThorn Therapeutics Names Bill Martin, Ph.D., President and Chief Operating Officer
- October 11, 2018 BlackThorn Therapeutics Announces Participation in Key Data Science and Cloud Computing Panels to Advance Therapeutic Development at 2018 BIO Investor Forum